ArticleGenes & cancer2019

Utilizing cell line-derived organoids to evaluate the efficacy of a novel LIFR-inhibitor, EC359 in targeting pancreatic tumor stroma.

Bradley R Hall et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.